George E. Koch

Dr. George E. Koch

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2022 in Urologic Clinics of North America
Verified
Journal Article
Closed access
GKGeorge E. Koch
George E. Koch
MKMelissa R. Kaufman
Melissa R. Kaufman

1 October 2021 in Urology
Verified
Journal Article
Closed access
GKGeorge E. Koch
George E. Koch
NJNiels V. Johnsen
Niels V. Johnsen

1 December 2021 in Journal of Urology
Verified
Journal Article
Closed access
GKGeorge E. Koch
George E. Koch
JHJennifer J. Huang
Jennifer J. Huang
WWWilliam J. Walton
William J. Walton
BDBradley M. Dennis
Bradley M. Dennis
OGOscar D. Guillamondegui
Oscar D. Guillamondegui
NJNiels V. Johnsen
Niels V. Johnsen
AUA Urotrauma guidelines recommend delayed-phase imaging on presentation for all renal injuries, although data to support it are anecdotal. Forgoing delays risks unrecognized collecting system injuries. We hypothesized that renal trauma patients without admission delays have more complications from urinary extravasation. 1751 renal trauma patients from 2005 through 2020 were identified from our institutional trauma registry. Included patients had an estimated American Association for the Surgery of Trauma renal injury grade of III-V and a perinephric fluid collection. Propensity scores for receipt of delays imaging were calculated based on Injury Severity Score, arrival condition, admission systolic blood pressure, sex and renal injury grade. Propensity score-adjusted logistic regression was used to compare clinical outcomes between those with and without admission delays. Ninety (28.6%) of 315 patients had delays on presentation. Patients without delays had higher injury severity scores (29 vs. 23, p=0.002), fewer isolated renal injuries (27.6% vs. 38.9%, p=0.05) and lower grade renal injuries (56.9% vs. 41.1% grade 3, p=0.03). After propensity score adjustment, patients with delays were more likely to undergo immediate interventions (OR 11.75, 95% CI 2.99-78.10) and interval stent placement for urinary extravasation (OR 6.86, 95% CI 1.56-47.64) without a difference in urologic complications (OR 5.07, 95% CI 0.25-766.16). Delayed-phase imaging was associated with an increased odds of undergoing immediate and asymptomatic interval urologic interventions without a difference in the odds of a complication after high-grade renal trauma. Post-trauma urinary extravasation requires further research to determine which patients require imaging and intervention.

Verified
Journal Article
Open access
PDF file
ECEllen M Cahill
Ellen M Cahill
HPHiren V. Patel
Hiren V. Patel
GKGeorge E. Koch
George E. Koch
JSJoshua Sterling
Joshua Sterling
Urethroplasty is a highly effective surgical treatment for urethral stricture disease. While overall complication rates are low, surgical site infections and urinary tract infections (UTIs) represent the most common complications. Due to the prolonged need for catheterization following reconstruction, many urologists place patients on extended antibiotic prophylaxis postoperatively. However, antibiotic stewardship is important given the risks of antibiotic overuse including opportunistic infections and the emergence of multidrug-resistant organisms. There are currently no established guidelines for the management of antibiotics for patients undergoing urethroplasty, specifically with regard to postoperative prophylaxis through the time of foley catheter removal. In this review, we examine the current literature regarding antibiotic prophylaxis and urethroplasty. Research has shown no clear benefit for extended antibiotic prophylaxis in preventing symptomatic urinary tract infections or stricture recurrence. This is congruent with evidence from other urologic procedures requiring indwelling catheters and/or stents including radical prostatectomy, hypospadias repair, and pyeloplasty. Prospective, randomized trials are needed to further understand the impact of antibiotic prophylaxis on both urethroplasty outcomes and its broader impact on recurrent UTIs and microbial resistance.

1 August 2024 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
GKGeorge E. Koch
George E. Koch
MKMelissa R. Kaufman
Melissa R. Kaufman
Background and Objective: While the modern artificial urinary sphincter (AUS) has benefited from incremental innovation, which has improved both device efficacy and complication rates, the foundational technology in use in Boston Scientific’s AMS800 can be traced back to the fundamental hydraulic tenets of the AS721. Research and development in adaptive technology and electronic integration stand to further improve AUS outcomes. Methods: The Medline online retrieval system was queried using the MeSH terms “artificial urinary sphincter”, “electronic”, “complications”, “history”, and “development” in various combinations. Publications were reviewed if applicable, and their reference lists were used to collect additional articles as needed. Final article inclusion was based on senior author discretion. Key Content and Findings: The AMS800 AUS is the gold standard for male stress incontinence implants. A 2015 consensus conference set out the goals for sphincter device development in the coming decades. A future ideal sphincter would adjust cuff pressure dynamically as well as function with minimal manipulation, or even via electronic control. Multiple new devices are in various states of development. During the next decade, artificial urinary sphincter technology is likely to include multiple Food and Drug Administration (FDA)-approved devices with varying features aimed at satisfying the 2015 consensus conference goal for an “ideal” AUS. Conclusions: The future of stress incontinence therapy lies in both continued innovation for the AUS, as well as advances in regenerative medicine. Electronic and adaptive developments in AUS technology will increase device safety, efficacy, and longevity while improving the user and caregiver experience. For some, regenerative medicine may even make AUS technology obsolete.

1 December 2024 in Journal of Urology
Verified
Journal Article
Closed access
GKGeorge E. Koch
George E. Koch
AAArash Amighi
Arash Amighi
ASAlexander J. Skokan
Alexander J. Skokan
JHJudith C. Hagedorn
Judith C. Hagedorn